首页 > 最新文献

Frontiers in medical technology最新文献

英文 中文
Exploration of the antiviral mechanism of gypsum-licorice compatibility pairing in Ma-Xing-Shi-Gan decoction from the perspective of metal-organic supramolecular interactions. 从金属-有机超分子相互作用的角度探讨麻杏石肝汤中石膏-甘草配伍的抗病毒机制。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1651390
Chang Lu, Ying Ma, Haoyu Zhao, Yu Zheng, Qun Zhao, Lili Lin, XiuZhen Chen, Linwei Chen, Gang Li, Rui Chen

The efficacy of the gypsum-licorice (SG-GC) pair was evaluated through its in vivo and in vitro anti-respiratory syncytial virus (RSV) activity. The results showed that SG-GC had significant efficacy against RSV infection in mice, which was close to that of the whole formula, and could significantly reduce the viral load in the lungs, improve the symptoms of lung injury, and reduce the inflammatory cell infiltration in the pathological sites. The decoction of single-flavored gypsum showed some anti-RSV efficacy, but not significant; when combined with sub-inhibitory concentrations of GA, it showed a significantly enhanced anti-RSV effect. The experimental results of this study suggest that gypsum may be a potential key antiviral substance, but its efficacy needs to be complemented by licorice; the significant enhancement of antiviral efficacy of SG-GC may be related to the formation of metal-organic supramolecules after the interaction of trace metal ions in gypsum and GA in licorice.

通过石膏-甘草(SG-GC)对体内和体外抗呼吸道合胞病毒(RSV)活性评价其有效性。结果表明,SG-GC对小鼠RSV感染具有显著的抑制作用,其效果与全方接近,可显著降低肺内病毒载量,改善肺损伤症状,减少病理部位炎症细胞浸润。单味石膏煎剂有一定的抗rsv作用,但不显著;当与亚抑制浓度的GA联合使用时,其抗rsv效果显著增强。本研究的实验结果提示,石膏可能是潜在的关键抗病毒物质,但其功效需要甘草的补充;皂苷gc抗病毒效果的显著增强可能与石膏中的微量金属离子与甘草中的GA相互作用后形成金属-有机超分子有关。
{"title":"Exploration of the antiviral mechanism of gypsum-licorice compatibility pairing in Ma-Xing-Shi-Gan decoction from the perspective of metal-organic supramolecular interactions.","authors":"Chang Lu, Ying Ma, Haoyu Zhao, Yu Zheng, Qun Zhao, Lili Lin, XiuZhen Chen, Linwei Chen, Gang Li, Rui Chen","doi":"10.3389/fmedt.2025.1651390","DOIUrl":"10.3389/fmedt.2025.1651390","url":null,"abstract":"<p><p>The efficacy of the gypsum-licorice (SG-GC) pair was evaluated through its <i>in vivo</i> and <i>in vitro</i> anti-respiratory syncytial virus (RSV) activity. The results showed that SG-GC had significant efficacy against RSV infection in mice, which was close to that of the whole formula, and could significantly reduce the viral load in the lungs, improve the symptoms of lung injury, and reduce the inflammatory cell infiltration in the pathological sites. The decoction of single-flavored gypsum showed some anti-RSV efficacy, but not significant; when combined with sub-inhibitory concentrations of GA, it showed a significantly enhanced anti-RSV effect. The experimental results of this study suggest that gypsum may be a potential key antiviral substance, but its efficacy needs to be complemented by licorice; the significant enhancement of antiviral efficacy of SG-GC may be related to the formation of metal-organic supramolecules after the interaction of trace metal ions in gypsum and GA in licorice.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1651390"},"PeriodicalIF":3.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12434118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145077021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computed tomography in the diagnosis of bilateral renal tuberculosis: diagnostic value, limitations, and future directions. 计算机断层扫描诊断双侧肾结核:诊断价值、局限性和未来发展方向。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-08-29 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1592592
Zhong Tian, Cheng Zhu, Neng Zhang, Bo Yu, Ni Fu

As equipment improves and technology advances, the application of Computed Tomography (CT) in clinical disease diagnosis has become increasingly widespread, particularly demonstrating significant advantages in diagnosing solid lesions. However, CT scans still face challenges, including insufficient sensitivity and an inability to assess renal function when diagnosing bilateral renal tuberculosis (BRTB). By reviewing relevant high-quality literature, we compared the sensitivity, specificity, advantages, and limitations of USG, KUB, IVU, MRI, PET-CT, and CT in the diagnosis of BRTB. CT offers higher clinical detection rates and reduces the economic burden on patients compared to other imaging methods, making it the preferred modality for imaging in patients with BRTB. AI-assisted diagnosis and the integration of CT with PET may represent promising future directions for CT imaging.

随着设备的改进和技术的进步,计算机断层扫描(CT)在临床疾病诊断中的应用越来越广泛,特别是在诊断实性病变方面表现出显著的优势。然而,CT扫描仍然面临挑战,包括在诊断双侧肾结核(BRTB)时灵敏度不足和无法评估肾功能。通过查阅相关高质量文献,比较USG、KUB、IVU、MRI、PET-CT和CT诊断BRTB的敏感性、特异性、优势和局限性。与其他成像方法相比,CT具有更高的临床检出率,减轻了患者的经济负担,是BRTB患者首选的成像方式。人工智能辅助诊断和CT与PET的结合可能是CT成像的未来发展方向。
{"title":"Computed tomography in the diagnosis of bilateral renal tuberculosis: diagnostic value, limitations, and future directions.","authors":"Zhong Tian, Cheng Zhu, Neng Zhang, Bo Yu, Ni Fu","doi":"10.3389/fmedt.2025.1592592","DOIUrl":"10.3389/fmedt.2025.1592592","url":null,"abstract":"<p><p>As equipment improves and technology advances, the application of Computed Tomography (CT) in clinical disease diagnosis has become increasingly widespread, particularly demonstrating significant advantages in diagnosing solid lesions. However, CT scans still face challenges, including insufficient sensitivity and an inability to assess renal function when diagnosing bilateral renal tuberculosis (BRTB). By reviewing relevant high-quality literature, we compared the sensitivity, specificity, advantages, and limitations of USG, KUB, IVU, MRI, PET-CT, and CT in the diagnosis of BRTB. CT offers higher clinical detection rates and reduces the economic burden on patients compared to other imaging methods, making it the preferred modality for imaging in patients with BRTB. AI-assisted diagnosis and the integration of CT with PET may represent promising future directions for CT imaging.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1592592"},"PeriodicalIF":3.8,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12426171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State machine design for an automated peritoneal dialysis machine. 自动腹膜透析机的状态机设计。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-08-29 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1630829
Wafa A Baroudi, Fatimah B Alnahdi, Raghad S Aljohani, Maryam A Alzuabi, Nora K Alsaqoub, Ibrahim A Aljamaan, Naif A Alrubai, Sajid Ali

According to the National Library of Medicine (NLM), chronic kidney disease (CKD) affects more than 10% of the world's population, and peritoneal dialysis (PD) is one of the promising treatments. Despite the advantages of the current PD machine over alternative treatments, it has certain limitations, such as high consumable costs, lengthy daily sessions, and a lack of portability. This work aims to implement a finite state machine design to modify the process of an automated, economical PD system. The proposed optimized process includes a flush system stage, where tubes are rinsed before and after each session to avoid contamination. This design is intended for use by only one patient to prevent contamination. Furthermore, a turbidity sensor is added to measure the efficiency of the dialysis process and reduce the current dialysis time, which can reach eight hours. The finite state machine design is developed using LabVIEW software, featuring a user-friendly interface that allows users to track the process's progress.

根据美国国家医学图书馆(NLM)的数据,慢性肾脏疾病(CKD)影响着世界上10%以上的人口,腹膜透析(PD)是一种很有前途的治疗方法。尽管目前的PD机器优于其他治疗方法,但它也有一定的局限性,例如耗材成本高、每日疗程长、缺乏可移植性。本工作旨在实现一种有限状态机设计,以修改自动化,经济的PD系统的过程。建议的优化过程包括冲洗系统阶段,在每次会话之前和之后冲洗管子以避免污染。这种设计仅供一名患者使用,以防止污染。此外,还增加了一个浊度传感器来测量透析过程的效率,并减少当前的透析时间,可以达到8小时。有限状态机设计使用LabVIEW软件开发,具有用户友好的界面,允许用户跟踪过程的进度。
{"title":"State machine design for an automated peritoneal dialysis machine.","authors":"Wafa A Baroudi, Fatimah B Alnahdi, Raghad S Aljohani, Maryam A Alzuabi, Nora K Alsaqoub, Ibrahim A Aljamaan, Naif A Alrubai, Sajid Ali","doi":"10.3389/fmedt.2025.1630829","DOIUrl":"10.3389/fmedt.2025.1630829","url":null,"abstract":"<p><p>According to the National Library of Medicine (NLM), chronic kidney disease (CKD) affects more than 10% of the world's population, and peritoneal dialysis (PD) is one of the promising treatments. Despite the advantages of the current PD machine over alternative treatments, it has certain limitations, such as high consumable costs, lengthy daily sessions, and a lack of portability. This work aims to implement a finite state machine design to modify the process of an automated, economical PD system. The proposed optimized process includes a flush system stage, where tubes are rinsed before and after each session to avoid contamination. This design is intended for use by only one patient to prevent contamination. Furthermore, a turbidity sensor is added to measure the efficiency of the dialysis process and reduce the current dialysis time, which can reach eight hours. The finite state machine design is developed using LabVIEW software, featuring a user-friendly interface that allows users to track the process's progress.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1630829"},"PeriodicalIF":3.8,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12426040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145066943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomaterials in tissue repair and regeneration: key insights from extracellular matrix biology. 组织修复和再生中的生物材料:来自细胞外基质生物学的关键见解。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1565810
Sakhavat Abolhasani, Yasin Ahmadi, Yavar Rostami, Erfan Baravar, Davood Fattahi

The extracellular matrix (ECM) serves as a dynamic biological framework that orchestrates cellular behavior through biomechanical and biochemical cues, playing a pivotal role in tissue homeostasis and repair. Despite significant advancements in biomaterial design, current regenerative strategies often fail to fully replicate the ECM's complexity, leading to suboptimal healing outcomes. This review comprehensively examines ECM biology and its application in biomaterial engineering, highlighting structural-functional relationships, integrin-mediated signaling, and ECM remodeling mechanisms in wound healing. We analyze diverse biomaterial classes-including ECM-based scaffolds, synthetic polymers, natural biomaterials, bioceramics, and composites-focusing on their design principles, fabrication techniques, degradation profiles, and clinical applications. Key challenges such as immunogenicity, vascularization, mechanical mismatch, and regulatory hurdles are critically evaluated. Innovations in decellularization, biofunctionalization, and advanced manufacturing (e.g., 3D bioprinting, electrospinning) are discussed as promising avenues to enhance biomimicry and therapeutic efficacy. Furthermore, we explore clinically approved ECM-derived products and underscore the need for standardized protocols to bridge translational gaps. By integrating emerging research with clinical perspectives, this review provides a roadmap for developing next-generation ECM-inspired biomaterials that address unmet needs in regenerative medicine, emphasizing interdisciplinary collaboration to optimize safety, functionality, and patient outcomes.

细胞外基质(ECM)是一个动态的生物框架,通过生物力学和生化线索协调细胞行为,在组织稳态和修复中起着关键作用。尽管生物材料设计取得了重大进展,但目前的再生策略往往无法完全复制ECM的复杂性,导致愈合效果不理想。本文综述了ECM生物学及其在生物材料工程中的应用,重点介绍了结构-功能关系、整合素介导的信号传导以及伤口愈合中的ECM重塑机制。我们分析了不同的生物材料类别,包括基于ecm的支架、合成聚合物、天然生物材料、生物陶瓷和复合材料,重点关注它们的设计原则、制造技术、降解概况和临床应用。关键挑战,如免疫原性、血管化、机械失配和监管障碍进行了批判性评估。在去细胞化、生物功能化和先进制造(例如,3D生物打印、静电纺丝)方面的创新被认为是提高仿生学和治疗效果的有希望的途径。此外,我们探索临床批准的ecm衍生产品,并强调需要标准化协议来弥合翻译差距。通过将新兴研究与临床观点相结合,本综述为开发下一代ecm启发的生物材料提供了路线图,以解决再生医学中未满足的需求,强调跨学科合作以优化安全性、功能和患者预后。
{"title":"Biomaterials in tissue repair and regeneration: key insights from extracellular matrix biology.","authors":"Sakhavat Abolhasani, Yasin Ahmadi, Yavar Rostami, Erfan Baravar, Davood Fattahi","doi":"10.3389/fmedt.2025.1565810","DOIUrl":"10.3389/fmedt.2025.1565810","url":null,"abstract":"<p><p>The extracellular matrix (ECM) serves as a dynamic biological framework that orchestrates cellular behavior through biomechanical and biochemical cues, playing a pivotal role in tissue homeostasis and repair. Despite significant advancements in biomaterial design, current regenerative strategies often fail to fully replicate the ECM's complexity, leading to suboptimal healing outcomes. This review comprehensively examines ECM biology and its application in biomaterial engineering, highlighting structural-functional relationships, integrin-mediated signaling, and ECM remodeling mechanisms in wound healing. We analyze diverse biomaterial classes-including ECM-based scaffolds, synthetic polymers, natural biomaterials, bioceramics, and composites-focusing on their design principles, fabrication techniques, degradation profiles, and clinical applications. Key challenges such as immunogenicity, vascularization, mechanical mismatch, and regulatory hurdles are critically evaluated. Innovations in decellularization, biofunctionalization, and advanced manufacturing (e.g., 3D bioprinting, electrospinning) are discussed as promising avenues to enhance biomimicry and therapeutic efficacy. Furthermore, we explore clinically approved ECM-derived products and underscore the need for standardized protocols to bridge translational gaps. By integrating emerging research with clinical perspectives, this review provides a roadmap for developing next-generation ECM-inspired biomaterials that address unmet needs in regenerative medicine, emphasizing interdisciplinary collaboration to optimize safety, functionality, and patient outcomes.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1565810"},"PeriodicalIF":3.8,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394198/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144983853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in pericardium extracellular matrix for tissue regeneration, along with a short insight into artificial intelligence. 心包细胞外基质用于组织再生的最新进展,以及对人工智能的简短见解。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-08-14 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1503153
Parand Shariat Rad, Mozafar Khazaei, Elham Ghanbari, Mehdi Rashidi, Leila Rezakhani

Medical science is striving to find new solutions to treat various diseases. Tissue engineering with a great potential to develop tissues and even organs from synthetic and biological materials, open a new gate toward absolute treatments. Although in tissue engineering as a subtype of regenerative medicine, decellularized tissues are new, promising way to fill the previous methods gaps. Outside of the biological aspects, artificial intelligence (AI) and machine learning (ML) are applied to tissue engineering. Decellularization is a very important area where AI supports protocols and ensures the process is repeated identically each time. It also greatly assists in monitoring the extracellular matrix (ECM) to ensure it remains intact. Nonetheless, the use of AI in tissue engineering is not fully discussed in scientific articles. Although based on the tissue used for decellularization these features could vary, to optimize decellularization we need new method to reach high accuracy. In these current days, Pericardium, a double-layered membrane around the heart of mammalians, as a natural ECM has been utilized in cardiac surgery for many years. However, the use of decellularized pericardium as a scaffold for tissue engineering has gained significant attention in recent times, due to its retention strength, flexibility, supports for cell growth and differentiation, etc. That altogether put it among the top choices for tissue engineering and regenerative medicine. In this review we aim to cover the different decellularization methods, application of decellularized pericardium, commercial products that are available and challenges and future direction of this potent therapy.

医学正在努力寻找治疗各种疾病的新方法。组织工程具有从合成和生物材料中发展组织甚至器官的巨大潜力,为绝对治疗打开了新的大门。虽然在组织工程中作为再生医学的一个分支,脱细胞组织是一种新的、有前途的方法,可以填补以往方法的空白。除了生物方面,人工智能(AI)和机器学习(ML)也应用于组织工程。去细胞化是人工智能支持协议的一个非常重要的领域,并确保每次都重复相同的过程。它还极大地帮助监测细胞外基质(ECM),以确保其保持完整。然而,人工智能在组织工程中的应用并没有在科学文章中得到充分的讨论。尽管基于用于脱细胞的组织,这些特征可能会有所不同,但为了优化脱细胞,我们需要新的方法来达到高精度。心包膜是哺乳动物心脏周围的一层双层膜,作为一种天然的体外外膜已在心脏外科中应用多年。然而,近年来,由于脱细胞心包具有保留强度、柔韧性、支持细胞生长和分化等优点,其作为组织工程支架的应用受到了广泛的关注。这使它成为组织工程和再生医学的首选。在这篇综述中,我们旨在涵盖不同的脱细胞方法,脱细胞心包的应用,现有的商业产品,挑战和未来的发展方向。
{"title":"Recent advances in pericardium extracellular matrix for tissue regeneration, along with a short insight into artificial intelligence.","authors":"Parand Shariat Rad, Mozafar Khazaei, Elham Ghanbari, Mehdi Rashidi, Leila Rezakhani","doi":"10.3389/fmedt.2025.1503153","DOIUrl":"10.3389/fmedt.2025.1503153","url":null,"abstract":"<p><p>Medical science is striving to find new solutions to treat various diseases. Tissue engineering with a great potential to develop tissues and even organs from synthetic and biological materials, open a new gate toward absolute treatments. Although in tissue engineering as a subtype of regenerative medicine, decellularized tissues are new, promising way to fill the previous methods gaps. Outside of the biological aspects, artificial intelligence (AI) and machine learning (ML) are applied to tissue engineering. Decellularization is a very important area where AI supports protocols and ensures the process is repeated identically each time. It also greatly assists in monitoring the extracellular matrix (ECM) to ensure it remains intact. Nonetheless, the use of AI in tissue engineering is not fully discussed in scientific articles. Although based on the tissue used for decellularization these features could vary, to optimize decellularization we need new method to reach high accuracy. In these current days, Pericardium, a double-layered membrane around the heart of mammalians, as a natural ECM has been utilized in cardiac surgery for many years. However, the use of decellularized pericardium as a scaffold for tissue engineering has gained significant attention in recent times, due to its retention strength, flexibility, supports for cell growth and differentiation, etc. That altogether put it among the top choices for tissue engineering and regenerative medicine. In this review we aim to cover the different decellularization methods, application of decellularized pericardium, commercial products that are available and challenges and future direction of this potent therapy.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1503153"},"PeriodicalIF":3.8,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12400526/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cooling devices used to avoid warm ischemia time injury during kidney transplantation. Systematic review and meta-analysis. 肾移植中避免热缺血时间损伤的冷却装置。系统回顾和荟萃分析。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-08-13 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1600784
Marco A Arizmendi-Villarreal, Alejandro Diaz Gonzalez-Colmenero, Jorge A Cantú-Hernández, Javier Sanchez-Maldonado, Gerardo E Muñoz-Maldonado, Edelmiro Perez-Rodriguez, Homero A Zapata-Chavira, Rene Rodriguez-Gutierrez, Francisco J Reyna-Sepulveda

Introduction: Warm ischemia during kidney transplantation contributes to graft dysfunction. External cooling devices have been developed to preserve graft during anastomosis, with promising results in experimental models. A systematic review and meta-analysis were conducted to evaluate the effectiveness of renal cooling devices.

Methods: A comprehensive search of seven databases was performed from inception to January 6, 2023. Eligible studies were randomized, prospective, and included a control group. Four studies met the inclusion criteria. The protocol was registered in PROSPERO (CRD42023409480).

Results: All studies reported significantly lower reperfusion temperatures in kidneys treated with cooling devices compared to controls. Histological graft injury, showed no statistically significant difference (SMD -0.95; 95% CI -10.74 to 8.83). However, post-transplant urinary output was significantly higher in the cooling device groups (SMD 0.49; 95% CI 0.10 to 0.88).

Discussion: The overall risk of bias across included studies was high. Cooling devices effectively lower graft temperature and may improve early functional outcomes. However, evidence of histological benefit remains inconclusive. Further clinical trials are needed to confirm efficacy and standardize device implementation in human transplantation.

Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42023409480, PROSPERO CRD42023409480.

肾移植过程中的热缺血会导致移植物功能障碍。为了在吻合过程中保存移植物,已经开发了外部冷却装置,并在实验模型中取得了令人满意的结果。进行了系统回顾和荟萃分析,以评估肾脏冷却装置的有效性。方法:全面检索自成立至2023年1月6日的7个数据库。符合条件的研究是随机的、前瞻性的,并包括一个对照组。4项研究符合纳入标准。该协议已在PROSPERO (CRD42023409480)中注册。结果:所有研究都报道了与对照组相比,使用冷却装置处理的肾脏再灌注温度显著降低。组织学上移植物损伤差异无统计学意义(SMD -0.95; 95% CI -10.74 ~ 8.83)。然而,冷却装置组移植后尿量明显更高(SMD 0.49; 95% CI 0.10至0.88)。讨论:纳入研究的总体偏倚风险很高。冷却装置有效降低移植物温度,并可能改善早期功能预后。然而,组织学益处的证据仍不确定。需要进一步的临床试验来确认疗效并规范设备在人体移植中的应用。系统评价注册:https://www.crd.york.ac.uk/PROSPERO/view/CRD42023409480, PROSPERO CRD42023409480。
{"title":"Cooling devices used to avoid warm ischemia time injury during kidney transplantation. Systematic review and meta-analysis.","authors":"Marco A Arizmendi-Villarreal, Alejandro Diaz Gonzalez-Colmenero, Jorge A Cantú-Hernández, Javier Sanchez-Maldonado, Gerardo E Muñoz-Maldonado, Edelmiro Perez-Rodriguez, Homero A Zapata-Chavira, Rene Rodriguez-Gutierrez, Francisco J Reyna-Sepulveda","doi":"10.3389/fmedt.2025.1600784","DOIUrl":"10.3389/fmedt.2025.1600784","url":null,"abstract":"<p><strong>Introduction: </strong>Warm ischemia during kidney transplantation contributes to graft dysfunction. External cooling devices have been developed to preserve graft during anastomosis, with promising results in experimental models. A systematic review and meta-analysis were conducted to evaluate the effectiveness of renal cooling devices.</p><p><strong>Methods: </strong>A comprehensive search of seven databases was performed from inception to January 6, 2023. Eligible studies were randomized, prospective, and included a control group. Four studies met the inclusion criteria. The protocol was registered in PROSPERO (CRD42023409480).</p><p><strong>Results: </strong>All studies reported significantly lower reperfusion temperatures in kidneys treated with cooling devices compared to controls. Histological graft injury, showed no statistically significant difference (SMD -0.95; 95% CI -10.74 to 8.83). However, post-transplant urinary output was significantly higher in the cooling device groups (SMD 0.49; 95% CI 0.10 to 0.88).</p><p><strong>Discussion: </strong>The overall risk of bias across included studies was high. Cooling devices effectively lower graft temperature and may improve early functional outcomes. However, evidence of histological benefit remains inconclusive. Further clinical trials are needed to confirm efficacy and standardize device implementation in human transplantation.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/PROSPERO/view/CRD42023409480, PROSPERO CRD42023409480.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1600784"},"PeriodicalIF":3.8,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12380627/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144983834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of the novel 3D PreemieScanner for preterm infants' growth monitoring confirmed in a simulated setting. 在模拟环境中证实了新型3D早产儿扫描仪对早产儿生长监测的有效性。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-08-01 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1607538
Ronald H J van Gils, Onno K Helder, René F Kornelisse, Timothy M S Singowikromo, Irwin Reiss, Jenny Dankelman

Introduction: Preterm infants' growth is typically monitored through weight, body length (BL) and head circumference (HC). However, 3D cranial volume (CrV) is considered a more accurate indicator of brain growth than 2D HC. The PreemieScanner is a novel 3D measuring device that simultaneously measures BL, HC and CrV. Its clinical usability was tested in a simulated NICU setting.

Materials and methods: Three extremely low birth weight (ELBW; BW < 1,000 gram) dolls with Optiflow breathing systems, (tubes positioned either at the front or back of the head) were used. Nurses conducted scan sessions and marked anatomical landmarks on 3D PreemieScanner images. As control, nurses measured HC manually with a standard measuring tape. Key outcomes were: (1) Measurement success rate, (2) Precision-percentage within clinically allowed limits, ±0.4 cm for BL, ±0.3 cm for HC, ±12 ml for CrV, and 3) accuracy-mean or median measurement error (MME) relative to the ground truth.

Results: Thirty-five scan sessions resulted in 100% successful measurements for BL and HC; 80% for CrV. BL MME -3.3% (p < 0.001); 40% (42/105) within precision limits. HC MME (Optiflow-front) 0.0% (p = 0.63); 89% (51/57) within limits. HC MME (Optiflow-back) -0.4% (p = 0.91). 93% (43/46) within limits. MME HC measuring tape, (Optiflow-front) -0.8% (p < 0.001), 88% (50/57) within limits, and MME (Optiflow-back) -1.1% (p < 0.001), 83% (40/48) within limits. MME CrV (Optiflow-front) -1.8% (p = 0.01), 86% (31/36) within limits, MME CrV (Optiflow-back) -1.3% (p < 0.001), 98% (45/46) within limits.

Conclusions: The PreemieScanner is a reliable, comprehensive device for measuring BL, HC and CrV in ELBW infants. It integrates smoothly into routine care with minimal disturbance. HC measurements demonstrated higher accuracy and precision than traditional tape method. CrV measurements, with 93% within precision limits, can be regarded as acceptable, enabling development of CrV growth reference charts, enhancing clinical growth monitoring.

简介:早产儿的生长通常通过体重、体长(BL)和头围(HC)来监测。然而,3D颅体积(CrV)被认为是比2D HC更准确的脑生长指标。PreemieScanner是一种新型的3D测量设备,可以同时测量BL、HC和CrV。在模拟NICU环境中测试了其临床可用性。材料和方法:3例极低出生体重(ELBW; BW)结果:35次扫描,100%成功测量BL和HC, 80%成功测量CrV。BL MME -3.3% (p p = 0.63);89%(51/57)在限定范围内。HC MME (Optiflow-back) -0.4% (p = 0.91)。93%(43/46)在限定范围内。MME HC测量带,(Optiflow-front) -0.8% (p p = 0.01), 86%(31/36)在限定范围内,MME CrV (Optiflow-back) -1.3% (p)结论:PreemieScanner是一种可靠、全面的测量ELBW婴儿BL、HC和CrV的设备。它以最小的干扰顺利融入日常护理。与传统的卷尺法相比,HC测量具有更高的准确度和精密度。CrV测量值在精度限内93%,可接受,可制定CrV生长参考图,加强临床生长监测。
{"title":"Effectiveness of the novel 3D PreemieScanner for preterm infants' growth monitoring confirmed in a simulated setting.","authors":"Ronald H J van Gils, Onno K Helder, René F Kornelisse, Timothy M S Singowikromo, Irwin Reiss, Jenny Dankelman","doi":"10.3389/fmedt.2025.1607538","DOIUrl":"10.3389/fmedt.2025.1607538","url":null,"abstract":"<p><strong>Introduction: </strong>Preterm infants' growth is typically monitored through weight, body length (BL) and head circumference (HC). However, 3D cranial volume (CrV) is considered a more accurate indicator of brain growth than 2D HC. The PreemieScanner is a novel 3D measuring device that simultaneously measures BL, HC and CrV. Its clinical usability was tested in a simulated NICU setting.</p><p><strong>Materials and methods: </strong>Three extremely low birth weight (ELBW; BW < 1,000 gram) dolls with Optiflow breathing systems, (tubes positioned either at the front or back of the head) were used. Nurses conducted scan sessions and marked anatomical landmarks on 3D PreemieScanner images. As control, nurses measured HC manually with a standard measuring tape. Key outcomes were: (1) Measurement success rate, (2) Precision-percentage within clinically allowed limits, ±0.4 cm for BL, ±0.3 cm for HC, ±12 ml for CrV, and 3) accuracy-mean or median measurement error (MME) relative to the ground truth.</p><p><strong>Results: </strong>Thirty-five scan sessions resulted in 100% successful measurements for BL and HC; 80% for CrV. BL MME -3.3% (<i>p</i> < 0.001); 40% (42/105) within precision limits. HC MME (Optiflow-front) 0.0% (<i>p</i> = 0.63); 89% (51/57) within limits. HC MME (Optiflow-back) -0.4% (<i>p</i> = 0.91). 93% (43/46) within limits. MME HC measuring tape, (Optiflow-front) -0.8% (<i>p</i> < 0.001), 88% (50/57) within limits, and MME (Optiflow-back) -1.1% (<i>p</i> < 0.001), 83% (40/48) within limits. MME CrV (Optiflow-front) -1.8% (<i>p</i> = 0.01), 86% (31/36) within limits, MME CrV (Optiflow-back) -1.3% (<i>p</i> < 0.001), 98% (45/46) within limits.</p><p><strong>Conclusions: </strong>The PreemieScanner is a reliable, comprehensive device for measuring BL, HC and CrV in ELBW infants. It integrates smoothly into routine care with minimal disturbance. HC measurements demonstrated higher accuracy and precision than traditional tape method. CrV measurements, with 93% within precision limits, can be regarded as acceptable, enabling development of CrV growth reference charts, enhancing clinical growth monitoring.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1607538"},"PeriodicalIF":3.8,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12354455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144877544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remote, smart telemonitoring of COVID-19 survivors for early detection of deterioration in cardiac health (the PARTMO study). 对COVID-19幸存者进行远程智能远程监测,以早期发现心脏健康恶化(PARTMO研究)。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-07-24 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1534097
Josephine Sau Fan Chow, Nutan Maurya, Susan San Miguel, Rumbidzai Teramayi, Ahilan Parameswaran, Annamarie D'Souza, Gregory Melbourne, Joseph Descallar, Young Juhn, Enoch Chan, Jerome Pong
<p><strong>Introduction: </strong>This study aims to implement a virtual model of care in the primary healthcare setting, utilising biosensor technologies (S-Patch EX) to remotely monitor and identify clinical signs and symptoms of cardiovascular conditions (mainly arrhythmias) in patients post-COVID-19 infection.</p><p><strong>Methods: </strong>This open-label, non-randomised, observational study was conducted in patients aged 18 years and above, clinically diagnosed with COVID-19 after June 2021, and those residing within Greater Western Sydney. The study involved two arms: the remote monitoring (intervention) and standard care (control) groups. The intervention group comprised patients who were provided with an S-Patch EX to monitor their electrocardiogram. Data were transmitted in real-time to a mobile phone via Bluetooth technology, and results were generated through artificial intelligence (AI) algorithms. All the data were reviewed for arrhythmia detection and escalated to the participant's general practitioner (if detected) to determine the appropriate intervention. The control group was used to compare the rate of cardiac arrhythmia detection against the intervention group. The patient's demographic and longitudinal clinical data were obtained from the electronic medical record system, enabling exploration and comparison of the cohort's characteristics and outcomes. Descriptive analysis was conducted for categorical variables (frequencies and cross-tabulations) and continuous variables (means, standard deviations, and medians). Depending on the nature of data, the groups were compared using <i>t</i>-tests or Chi-square tests. Multivariable Cox regression was used to analyse time to first cardiovascular event post-COVID-19 infection.</p><p><strong>Outcome measures: </strong>The time to the patient's first cardiovascular event (mainly arrhythmias) post-COVID-19 infection.</p><p><strong>Results: </strong>Of 44 patients who provided consent, 40 commenced monitoring. Thirteen patients (32.5%) were detected by the AI algorithms from the S-Patch EX monitoring system to have cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. Univariate Cox regression demonstrated that arrhythmia was more likely to be detected in the remote monitoring group (13/40, 32.9%) as compared with the standard care group (7/200, 3.5%) [HR = 29.56 (9.95, 87.86), <i>p</i> < 0.0001]. Most of the patients were detected with arrhythmia within a 3-month timeframe of monitoring. Twenty-one patients (21/200, 10.5%) from the standard care group visited the emergency department and/or were admitted to the hospital post-COVID-19 infection due to chest pain, shortness of breath/dyspnoea, palpitations, dizziness/light-headedness/presyncope, and nausea. Two patients developed long COVID symptoms (progressive dyspnoea) 2-5 months post-COVID-19 infection.</p><p><strong>Conclusions: </strong>Considering the risk of developing car
本研究旨在在初级卫生保健环境中实施虚拟护理模型,利用生物传感器技术(S-Patch EX)远程监测和识别covid -19感染后患者心血管疾病(主要是心律失常)的临床体征和症状。方法:这项开放标签、非随机、观察性研究纳入了2021年6月以后临床诊断为COVID-19的18岁及以上患者,以及居住在大西悉尼地区的患者。这项研究包括两组:远程监测组(干预组)和标准护理组(对照组)。干预组包括使用S-Patch EX监测心电图的患者。数据通过蓝牙技术实时传输到手机上,并通过人工智能(AI)算法生成结果。检查心律失常检测的所有数据,并升级到参与者的全科医生(如果检测到),以确定适当的干预措施。对照组与干预组比较心律失常检出率。从电子病历系统中获得患者的人口统计学和纵向临床数据,以便对队列的特征和结果进行探索和比较。对分类变量(频率和交叉表)和连续变量(均值、标准差和中位数)进行描述性分析。根据数据的性质,使用t检验或卡方检验对各组进行比较。采用多变量Cox回归分析covid -19感染后发生首次心血管事件的时间。观察指标:患者在covid -19感染后发生首次心血管事件(主要是心律失常)的时间。结果:在提供同意的44例患者中,40例开始监测。S-Patch EX监测系统的人工智能算法检测到13例(32.5%)患者存在心律失常,包括房颤、室上性心动过速和室性心动过速。单因素Cox回归显示,远程监测组(13/40,32.9%)比标准护理组(7/200,3.5%)更容易发现心律失常[HR = 29.56 (9.95, 87.86), p]。结论:考虑到covid -19感染后发生心血管并发症的风险,建议对所有患者(包括年轻、健康和无症状人群)进行定期监测、重新评估和评估,作为covid -19感染后管理的一部分。建议开展一项样本量更大、随访时间更长的随机介入性研究,以更好地了解covid - 19感染后的心血管影响。
{"title":"Remote, smart telemonitoring of COVID-19 survivors for early detection of deterioration in cardiac health (the PARTMO study).","authors":"Josephine Sau Fan Chow, Nutan Maurya, Susan San Miguel, Rumbidzai Teramayi, Ahilan Parameswaran, Annamarie D'Souza, Gregory Melbourne, Joseph Descallar, Young Juhn, Enoch Chan, Jerome Pong","doi":"10.3389/fmedt.2025.1534097","DOIUrl":"10.3389/fmedt.2025.1534097","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;This study aims to implement a virtual model of care in the primary healthcare setting, utilising biosensor technologies (S-Patch EX) to remotely monitor and identify clinical signs and symptoms of cardiovascular conditions (mainly arrhythmias) in patients post-COVID-19 infection.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This open-label, non-randomised, observational study was conducted in patients aged 18 years and above, clinically diagnosed with COVID-19 after June 2021, and those residing within Greater Western Sydney. The study involved two arms: the remote monitoring (intervention) and standard care (control) groups. The intervention group comprised patients who were provided with an S-Patch EX to monitor their electrocardiogram. Data were transmitted in real-time to a mobile phone via Bluetooth technology, and results were generated through artificial intelligence (AI) algorithms. All the data were reviewed for arrhythmia detection and escalated to the participant's general practitioner (if detected) to determine the appropriate intervention. The control group was used to compare the rate of cardiac arrhythmia detection against the intervention group. The patient's demographic and longitudinal clinical data were obtained from the electronic medical record system, enabling exploration and comparison of the cohort's characteristics and outcomes. Descriptive analysis was conducted for categorical variables (frequencies and cross-tabulations) and continuous variables (means, standard deviations, and medians). Depending on the nature of data, the groups were compared using &lt;i&gt;t&lt;/i&gt;-tests or Chi-square tests. Multivariable Cox regression was used to analyse time to first cardiovascular event post-COVID-19 infection.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome measures: &lt;/strong&gt;The time to the patient's first cardiovascular event (mainly arrhythmias) post-COVID-19 infection.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of 44 patients who provided consent, 40 commenced monitoring. Thirteen patients (32.5%) were detected by the AI algorithms from the S-Patch EX monitoring system to have cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. Univariate Cox regression demonstrated that arrhythmia was more likely to be detected in the remote monitoring group (13/40, 32.9%) as compared with the standard care group (7/200, 3.5%) [HR = 29.56 (9.95, 87.86), &lt;i&gt;p&lt;/i&gt; &lt; 0.0001]. Most of the patients were detected with arrhythmia within a 3-month timeframe of monitoring. Twenty-one patients (21/200, 10.5%) from the standard care group visited the emergency department and/or were admitted to the hospital post-COVID-19 infection due to chest pain, shortness of breath/dyspnoea, palpitations, dizziness/light-headedness/presyncope, and nausea. Two patients developed long COVID symptoms (progressive dyspnoea) 2-5 months post-COVID-19 infection.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Considering the risk of developing car","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1534097"},"PeriodicalIF":3.8,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12328397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144801320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of magnetocardiography as a non-invasive tool for functional assessment of myocardial ischemia in patients with stable coronary artery disease. 心磁图作为一种无创工具评估稳定型冠状动脉疾病患者心肌缺血功能的有效性
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-07-22 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1611046
Wen-Fei He, Li-Huan Zeng, Nan-Shan Xie, Hao-Xing Liu, Wen-Min Cui, Ying Wang, Zhi-Jian Zhang, Guan-Lun Ye, Zhi-Ying Qin, Zhi-Qiang Guo, Jun Ma, Jian-Fang Luo

Background: Identification of coronary ischemia in suspected coronary artery disease (CAD) remains challenging. Magnetocardiography (MCG) demonstrated comparably high diagnostic efficiency for detecting coronary ischemia in previous studies. However, limited evidence exists comparing MCG vs. computed tomography angiography-derived fractional flow reserve (CTFFR) in suspected CAD patients.

Methods: A total of 291 patients with CTA-confirmed diameter stenosis ranging from 30% to 90% were included and divided into two groups based on the CTFFR values, the stable coronary artery disease (SCAD) group (≤0.8) and the non-SCAD group (>0.8). Magnetic field map (MFM) parameters were employed to construct a diagnostic model. The performance of the models was evaluated using receiver operating characteristic (ROC) curves, accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).

Results: Patients with SCAD showed a mean MCG score of 5.6 ± 2.9, while the non-SCAD group demonstrated a mean score of 2.0 ± 1.9 (P < 0.001). The area under the curve (AUC) for ROC analysis was 0.824 (95% CI: 0.772-0.877). Point 5 was selected as the operational cutoff value providing a favorable balance of sensitivity and specificity. Ultimately, MCG score yielded a sensitivity of 69.6%, specificity of 87.9%, PPV of 72.7%, NPV of 86.2%, and accuracy of 82.1%.

Conclusions: Compared to CTFFR, MCG demonstrated superior specificity and moderate sensitivity for detecting CAD in patients with diameter stenosis CTA ranging from 30% to 90%. It may provide an alternative to functional evaluation prior to invasive or radiation exposure methods.

背景:疑似冠状动脉疾病(CAD)的冠状动脉缺血鉴定仍然具有挑战性。在以往的研究中,心脏磁图(MCG)在检测冠状动脉缺血方面显示出相当高的诊断效率。然而,在疑似CAD患者中,MCG与ct血管造影衍生的分数血流储备(CTFFR)的比较证据有限。方法:共纳入291例经cta确诊的内径狭窄,范围为30% ~ 90%,根据CTFFR值分为稳定性冠状动脉病变(SCAD)组(≤0.8)和非SCAD组(>0.8)。利用磁场图(MFM)参数构建诊断模型。采用受试者工作特征(ROC)曲线、准确性、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)评价模型的性能。结果:SCAD患者的平均MCG评分为5.6±2.9分,非SCAD组的平均评分为2.0±1.9分(P)。结论:与CTFFR相比,MCG在CTA直径狭窄患者中检测CAD的特异性和灵敏度较高,范围为30% ~ 90%。它可以在侵入性或辐射暴露方法之前提供功能评估的替代方法。
{"title":"Effectiveness of magnetocardiography as a non-invasive tool for functional assessment of myocardial ischemia in patients with stable coronary artery disease.","authors":"Wen-Fei He, Li-Huan Zeng, Nan-Shan Xie, Hao-Xing Liu, Wen-Min Cui, Ying Wang, Zhi-Jian Zhang, Guan-Lun Ye, Zhi-Ying Qin, Zhi-Qiang Guo, Jun Ma, Jian-Fang Luo","doi":"10.3389/fmedt.2025.1611046","DOIUrl":"10.3389/fmedt.2025.1611046","url":null,"abstract":"<p><strong>Background: </strong>Identification of coronary ischemia in suspected coronary artery disease (CAD) remains challenging. Magnetocardiography (MCG) demonstrated comparably high diagnostic efficiency for detecting coronary ischemia in previous studies. However, limited evidence exists comparing MCG vs. computed tomography angiography-derived fractional flow reserve (CTFFR) in suspected CAD patients.</p><p><strong>Methods: </strong>A total of 291 patients with CTA-confirmed diameter stenosis ranging from 30% to 90% were included and divided into two groups based on the CTFFR values, the stable coronary artery disease (SCAD) group (≤0.8) and the non-SCAD group (>0.8). Magnetic field map (MFM) parameters were employed to construct a diagnostic model. The performance of the models was evaluated using receiver operating characteristic (ROC) curves, accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).</p><p><strong>Results: </strong>Patients with SCAD showed a mean MCG score of 5.6 ± 2.9, while the non-SCAD group demonstrated a mean score of 2.0 ± 1.9 (<i>P</i> < 0.001). The area under the curve (AUC) for ROC analysis was 0.824 (95% CI: 0.772-0.877). Point 5 was selected as the operational cutoff value providing a favorable balance of sensitivity and specificity. Ultimately, MCG score yielded a sensitivity of 69.6%, specificity of 87.9%, PPV of 72.7%, NPV of 86.2%, and accuracy of 82.1%.</p><p><strong>Conclusions: </strong>Compared to CTFFR, MCG demonstrated superior specificity and moderate sensitivity for detecting CAD in patients with diameter stenosis CTA ranging from 30% to 90%. It may provide an alternative to functional evaluation prior to invasive or radiation exposure methods.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1611046"},"PeriodicalIF":3.8,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12321830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144791037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New insights in fluid monitoring for surgical patients. A concept study. 外科病人液体监测的新见解。概念研究。
IF 3.8 Q3 ENGINEERING, BIOMEDICAL Pub Date : 2025-07-21 eCollection Date: 2025-01-01 DOI: 10.3389/fmedt.2025.1619238
Audrius Andrijauskas, Povilas Andrijauskas, Darius Dilijonas, Tomas Jovaiša, Vaidotas Marozas, Edgaras Stankevičius, Axel Kerroum, Darius Čincikas, Saulė Švedienė, Giedrius Kvederas, Narūnas Porvaneckas, Christer Svensen

Purpose: This study evaluates the primary hypothesis of red cell mass (RCM) dependent amplitude of homeostatically acceptable limits of fluctuation in plasma dilution by exploring the correlation between RCM-specific equilibrated hematocrit (EQ_Hct) and amplitude of plasma dilution during perioperative mini Volume Loading Test (mVLT).

Materials and methods: We retrospectively analyzed data from our previous RCTs, including 1,651 invasive arterial plasma dilution (aPD), 1,645 noninvasive "capillary" plasma dilution (cPD) and 236 estimates of EQ_Hct from 236 perioperative mVLT sessions. The cPD was estimated using noninvasive hemoglobin (SpHb, Masimo Radical 7, Irvine, CA) measurement. Fixed number of crystalloid boluses was used in 36 and 48 elective total knee arthroplasty (TKA) patients, and individualized number of boluses in 34 total hip arthroplasty (THA) patients for whom the number of boluses depended on the advices by our prototype automated clinical decision support system (ACDSS).

Results: The primary hypothesis was confirmed-aPD decreased as EQ_Hct decreased when EQ_Hct <40%, and a very weak positive correlation was found between EQ_Hct and absolute aPD (Spearman's correlation coefficient 0.1025, p < 0.001). It was also confirmed when non-invasive data sets were used. A very weak negative correlation between HctEQ values and absolute cPD values (Spearman's correlation coefficient 0.0640, p= 0.0149).

Conclusion: This study points to the feasibility of Photoplethysmography (PPG) based estimates of hemoglobin concentration for continuous noninvasive monitoring of fluid accumulation and detecting imminent edema using the Homeostatic Blood States (HBS) theory and transcapillary reflux model. The ACDSS-guided fluid loading has a potential to minimise unnecessary fluid accumulation. Further research is needed to explore and improve these techniques.

目的:本研究通过探讨围手术期小体积负荷试验(mVLT)中红细胞特异性平衡红细胞压积(EQ_Hct)与血浆稀释幅度之间的相关性,评估红细胞体积(RCM)依赖于血浆稀释的稳态可接受波动极限幅度的主要假设。材料和方法:我们回顾性分析了之前的随机对照试验的数据,包括1651例有创动脉血浆稀释(aPD), 1645例无创“毛细血管”血浆稀释(cPD)和236例围手术期mVLT的EQ_Hct估计。cPD使用无创血红蛋白(SpHb, Masimo Radical 7, Irvine, CA)测量来估计。36例和48例选择性全膝关节置换术(TKA)患者使用固定数量的晶体丸,34例全髋关节置换术(THA)患者使用个性化数量的晶体丸,其中晶体丸的数量取决于我们的原型自动临床决策支持系统(ACDSS)的建议。结果:证实了原假设,当EQ_Hct p = 0.0149时,apd随EQ_Hct降低而降低。结论:本研究指出,利用稳态血液状态(HBS)理论和经毛细血管反流模型,基于光容积脉搏波(PPG)估计血红蛋白浓度,对液体积聚进行持续无创监测和检测迫在眉睫的水肿是可行的。acdss导向的流体加载有可能最大限度地减少不必要的流体积聚。需要进一步的研究来探索和改进这些技术。
{"title":"New insights in fluid monitoring for surgical patients. A concept study.","authors":"Audrius Andrijauskas, Povilas Andrijauskas, Darius Dilijonas, Tomas Jovaiša, Vaidotas Marozas, Edgaras Stankevičius, Axel Kerroum, Darius Čincikas, Saulė Švedienė, Giedrius Kvederas, Narūnas Porvaneckas, Christer Svensen","doi":"10.3389/fmedt.2025.1619238","DOIUrl":"10.3389/fmedt.2025.1619238","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the primary hypothesis of red cell mass (RCM) dependent amplitude of homeostatically acceptable limits of fluctuation in plasma dilution by exploring the correlation between RCM-specific equilibrated hematocrit (EQ_Hct) and amplitude of plasma dilution during perioperative mini Volume Loading Test (mVLT).</p><p><strong>Materials and methods: </strong>We retrospectively analyzed data from our previous RCTs, including 1,651 invasive arterial plasma dilution (aPD), 1,645 noninvasive \"capillary\" plasma dilution (cPD) and 236 estimates of EQ_Hct from 236 perioperative mVLT sessions. The cPD was estimated using noninvasive hemoglobin (SpHb, Masimo Radical 7, Irvine, CA) measurement. Fixed number of crystalloid boluses was used in 36 and 48 elective total knee arthroplasty (TKA) patients, and individualized number of boluses in 34 total hip arthroplasty (THA) patients for whom the number of boluses depended on the advices by our prototype automated clinical decision support system (ACDSS).</p><p><strong>Results: </strong>The primary hypothesis was confirmed-aPD decreased as EQ_Hct decreased when EQ_Hct <40%, and a very weak positive correlation was found between EQ_Hct and absolute aPD (Spearman's correlation coefficient 0.1025, <i>p</i> < 0.001). It was also confirmed when non-invasive data sets were used. A very weak negative correlation between HctEQ values and absolute cPD values (Spearman's correlation coefficient 0.0640, <i>p</i> <i>=</i> 0.0149).</p><p><strong>Conclusion: </strong>This study points to the feasibility of Photoplethysmography (PPG) based estimates of hemoglobin concentration for continuous noninvasive monitoring of fluid accumulation and detecting imminent edema using the Homeostatic Blood States (HBS) theory and transcapillary reflux model. The ACDSS-guided fluid loading has a potential to minimise unnecessary fluid accumulation. Further research is needed to explore and improve these techniques.</p>","PeriodicalId":94015,"journal":{"name":"Frontiers in medical technology","volume":"7 ","pages":"1619238"},"PeriodicalIF":3.8,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12318955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144786183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in medical technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1